Carbonaro TM

Drug Enforcement Administration, United States Department of Justice, Washington, District of Columbia.

11 papers

Interoceptive effects of N<sub>1</sub>-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide.

Berquist MD, Gannon BM, Honeywell KM +8

Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.

Shaw HE, Patel DR, Gannon BM +4

ArticlePsilocybin

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [<sup>11</sup>C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.

Barrett FS, Zhou Y, Carbonaro TM +4

ArticlePsilocybin

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.

Garcia-Romeu A, Barrett FS, Carbonaro TM +2

ArticlePsilocybin

Discriminative Stimulus Effects of Substituted Tryptamines in Rats.

Gatch MB, Hoch A, Carbonaro TM

ArticlePsilocybin

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.

Carbonaro TM, Johnson MW, Griffiths RR

ArticlePsilocybin

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Barrett FS, Carbonaro TM, Hurwitz E +2

ArticlePsilocybin

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Carbonaro TM, Johnson MW, Hurwitz E +1

ArticlePsilocybin

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

Carbonaro TM, Bradstreet MP, Barrett FS +4

Neuropharmacology of N,N-dimethyltryptamine.

Carbonaro TM, Gatch MB

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Carbonaro TM, Forster MJ, Gatch MB